Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-25-000349·Indivior Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
INDIVIOR PLC
Ordinary Shares · CUSIP: G4766E116
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 4,665,206 · Class: 3.7%
- Morgan Stanley & Co. International plc
Shares: 3,972,198 · Class: 3.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000349
- Form type
- SCHEDULE 13G/A
- Filer
- Indivior Pharmaceuticals, Inc.
- CIK
- CIK 1625297
- Filed
- May 06, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership